Navidea Biopharmaceuticals Financials

Navidea Biopharmaceutica Stock Summary

Navidea Biopharmaceutica competes with NovaBay Pharmaceuticals, Cyclacel Pharmaceuticals, and Tenax Therapeutics. Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio. Navidea Biopharmaceutica operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 11 people.

Navidea Biopharmaceutica Key Financial Ratios

Navidea Biopharmaceutica's financial ratios allow both analysts and investors to convert raw data from Navidea Biopharmaceutica's financial statements into concise, actionable information that can be used to evaluate the performance of Navidea Biopharmaceutica over time and compare it to other companies across industries.

Navidea Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Navidea Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Navidea Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Navidea Biopharmaceutica competition to find correlations between indicators driving Navidea Biopharmaceutica's intrinsic value. More Info.Navidea Biopharmaceuticals is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Navidea Biopharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Navidea Biopharmaceutica's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Navidea Biopharmaceutica Market Pulse

Along with financial statement analysis, the daily predictive indicators of Navidea Biopharmaceutica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Navidea Biopharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Navidea Biopharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Navidea Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Navidea Biopharmaceutica's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.